Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0671 | 0.0671 |
Echinococcus multilocularis | geminin | 0.0205 | 0.0671 | 0.0671 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.0671 | 0.0671 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0911 | 1 | 1 |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.0154 | 0 | 0.5 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.0154 | 0 | 0.5 |
Echinococcus granulosus | acetylcholinesterase | 0.0911 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0911 | 1 | 1 |
Loa Loa (eye worm) | carboxylesterase | 0.0911 | 1 | 1 |
Onchocerca volvulus | 0.0154 | 0 | 0.5 | |
Echinococcus multilocularis | acetylcholinesterase | 0.0911 | 1 | 1 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0154 | 0 | 0.5 |
Onchocerca volvulus | 0.0154 | 0 | 0.5 | |
Echinococcus multilocularis | acetylcholinesterase | 0.0911 | 1 | 1 |
Onchocerca volvulus | 0.0154 | 0 | 0.5 | |
Onchocerca volvulus | 0.0154 | 0 | 0.5 | |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.0154 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0911 | 1 | 1 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.0154 | 0 | 0.5 |
Onchocerca volvulus | 0.0154 | 0 | 0.5 | |
Echinococcus granulosus | carboxylesterase 5A | 0.0911 | 1 | 1 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.0154 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0911 | 1 | 1 |
Echinococcus granulosus | acetylcholinesterase | 0.0911 | 1 | 1 |
Brugia malayi | Carboxylesterase family protein | 0.0911 | 1 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0911 | 1 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.0671 | 0.0671 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | 6.5131 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 29.9349 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.